secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2022-03-22T23:59:59+00:00
Accession:  0001564590-22-011356
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Xenon issues 1.016M common shares on conversion of all Series 1 Preferred held by BVF Partners
--------------------------------------------------------------------------------

- Converted 1,016,000 Series 1 Preferred Shares into 1,016,000 common shares.
- Transaction was exempt under Section 3(a)(9) of the Securities Act.
- No Series 1 Preferred Shares remain outstanding after the conversion.
- BVF Partners L.P. affiliated funds were the sole holders of the converted shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000156459022011356/0001564590-22-011356-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000156459022011356/xene-8k_20220316.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-011356

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer